Rice Hall James & Associates, LLC Travere Therapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

$1.53 Billion
Q1 2025

A detailed history of Rice Hall James & Associates, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 88,617 shares of TVTX stock, worth $1.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

88,617

Previous 92,658 4.36%

Holding current value

$1.4 Million

Previous $1.61 Million 1.61%

% of portfolio

0.1%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$17.07 - $23.75 $68,979 - $95,973	-4,041 Reduced 4.36%	88,617 $1.59 Million
Q4 2024 Jan 31, 2025	SELL	$13.65 - $19.85 $28,364 - $41,248	-2,078 Reduced 2.19%	92,658 $1.61 Million
Q3 2024 Oct 28, 2024	BUY	$7.89 - $15.21 $146,454 - $282,328	18,562 Added 24.37%	94,736 $1.33 Million
Q2 2024 Aug 07, 2024	BUY	$5.26 - $8.28 $14,591 - $22,968	2,774 Added 3.78%	76,174 $626,000
Q1 2024 Apr 23, 2024	BUY	$7.18 - $9.82 $22,545 - $30,834	3,140 Added 4.47%	73,400 $565,000
Q4 2023 Feb 08, 2024	SELL	$5.44 - $9.5 $44,074 - $76,969	-8,102 Reduced 10.34%	70,260 $631,000
Q3 2023 Nov 02, 2023	SELL	$7.64 - $17.25 $11,314 - $25,547	-1,481 Reduced 1.85%	78,362 $700,000
Q2 2023 Jul 24, 2023	BUY	$15.3 - $22.61 $51,178 - $75,630	3,345 Added 4.37%	79,843 $1.23 Million
Q1 2023 May 11, 2023	BUY	$17.82 - $22.89 $5,167 - $6,638	290 Added 0.38%	76,498 $1.72 Million
Q4 2022 Jan 27, 2023	SELL	$18.47 - $26.14 $30,087 - $42,582	-1,629 Reduced 2.09%	76,208 $0
Q3 2022 Nov 01, 2022	SELL	$22.91 - $28.63 $553,368 - $691,529	-24,154 Reduced 23.68%	77,837 $1.92 Million
Q2 2022 Aug 08, 2022	BUY	$20.94 - $30.01 $50,842 - $72,864	2,428 Added 2.44%	101,991 $2.47 Million
Q1 2022 May 05, 2022	BUY	$23.61 - $30.6 $79,967 - $103,642	3,387 Added 3.52%	99,563 $2.57 Million
Q4 2021 Feb 14, 2022	SELL	$24.34 - $31.17 $317,150 - $406,145	-13,030 Reduced 11.93%	96,176 $2.99 Million
Q3 2021 Nov 09, 2021	BUY	$12.98 - $25.03 $30,879 - $59,546	2,379 Added 2.23%	109,206 $2.65 Million
Q2 2021 Jul 29, 2021	SELL	$14.11 - $26.4 $71,580 - $133,927	-5,073 Reduced 4.53%	106,827 $1.56 Million
Q1 2021 May 14, 2021	BUY	$23.37 - $31.77 $841 - $1,143	36 Added 0.03%	111,900 $2.79 Million
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $2.14 Million - $3.12 Million	111,864 New	111,864 $3.05 Million

Others Institutions Holding TVTX

# of Institutions

239

Shares Held

99.9M

Call Options Held

1.79M

Put Options Held

555K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.02B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Travere Therapeutics, Inc. Transaction History